<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Overall viral hepatitis screening rate according to epidemiological, clinical and therapeutic factors.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Factor</th>
    <th>N Patients</th>
    <th>Screening rate</th>
    <th>p value*</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Male gender</td>
    <td>233</td>
    <td>90.1%</td>
    <td>0.075</td>
   </tr>
   <tr>
    <td>Age â‰¥65 years</td>
    <td>227</td>
    <td>88.5%</td>
    <td>0.374</td>
   </tr>
   <tr>
    <td>Caucasian race</td>
    <td>398</td>
    <td>87.9%</td>
    <td>0.514</td>
   </tr>
   <tr>
    <td>DLBCL</td>
    <td>72</td>
    <td>97.2%</td>
    <td>0.003</td>
   </tr>
   <tr>
    <td>Multiple myeloma</td>
    <td>65</td>
    <td>93.8%</td>
    <td>0.074</td>
   </tr>
   <tr>
    <td>Chronic myeloid leukemia</td>
    <td>37</td>
    <td>48.6%</td>
    <td>&lt;0.001</td>
   </tr>
   <tr>
    <td>Anti-CD20-containing regimens</td>
    <td>166</td>
    <td>93.4%</td>
    <td>0.003</td>
   </tr>
   <tr>
    <td>Tyrosine-kinase inhibitors</td>
    <td>64</td>
    <td>62.5%</td>
    <td>&lt;0.001</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>*Comparison of rate of screening in contrast with the rest of the cohort.</p>
 </table-wrap-foot>
</table-wrap>
